Sante D. Pierdomenico

Sante D. Pierdomenico

Auto-generated profile, based on publicly available information

Sante D. Pierdomenico


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2005 in American Journal of Hypertension
Verified
Journal Article
Closed access
SPS Pierdomenico
S Pierdomenico
DLD Lapenna
D Lapenna
ABA Bucci
A Bucci
RDR Ditommaso
R Ditommaso
RDR Dimascio
R Dimascio
AMA Mezzetti
A Mezzetti
The aim of this study was to evaluate the cardiovascular outcome in apparently responder hypertensive patients with responder and masked hypertension, and in apparently resistant hypertensive patients with false and true resistant hypertension. The occurrence of fatal and nonfatal cardiovascular events was evaluated in 340 patients with responder hypertension (clinic blood pressure [BP] 135 or 85 mm Hg), 146 with false resistant hypertension (clinic BP >or=140 or 90 mm Hg and daytime BP or=140 or 90 mm Hg and daytime BP >135 or 85 mm Hg). During follow-up period (4.98 +/- 2.9 years), the event-rate per 100 patient-years was 0.87, 2.42, 1.2, and 4.1 in patients with responder, masked, false resistant, and true resistant hypertension, respectively. After adjustment for several covariates, including clinic BP (forced into the model), Cox regression analysis showed that cardiovascular risk was significantly higher in masked hypertension (masked versus responder hypertension, relative risk [RR] 2.28, 95% confidence interval [CI] 1.1-4.7, P < .05) and in true resistant hypertension (true resistant versus responder hypertension, RR 2.94, 95% CI 1.02-8.41, P < .05), whereas there was no significant difference between false resistant and responder hypertension. This study shows that patients with masked hypertension are at higher risk than those with responder hypertension, and that those with false resistant hypertension are at lower risk than those with true resistant hypertension. Ambulatory BP monitoring should be performed in treated hypertensive patients to obtain a better prognostic stratification.

1 January 2011 in American Journal of Hypertension
Verified
Journal Article
Closed access
SPS. D. Pierdomenico
S. D. Pierdomenico
FCF. Cuccurullo
F. Cuccurullo
The prognostic relevance of white-coat hypertension (WCH) and masked hypertension (MH) is controversial. The aim of this study was to perform an updated meta-analysis on the prognostic value of WCH and MH diagnosed by ambulatory monitoring in initially untreated subjects. We searched for articles evaluating cardiovascular outcome in WCH or MH or sustained hypertension (SH) in comparison with normotension, investigating untreated subjects at baseline or performing separate analysis for untreated or treated subjects, and reporting adjusted hazard ratio (HR) and 95% confidence interval (CI). Eight studies were identified. Five whole studies and untreated groups of three others were included in the meta-analysis. The pooled population consisted of 7,961 subjects who experienced 696 events. When compared with normotension, the overall adjusted HR was 0.96 (95% CI 0.65-1.42) for WCH (P = 0.85), 2.09 (1.55-2.81) for MH (P = 0.0001), and 2.59 (2.0-3.35) for SH (P = 0.0001). There was no significant difference between WCH and normotension according to normotensive subjects source (same or different study population) and follow-up length. Where reported, prevalence of drug therapy was higher in subjects with WCH than in those with normotension at follow-up. Cardiovascular risk is not significantly different between WCH and normotension, regardless of normotensive population type and follow-up length. However, at follow-up drug therapy was more frequent in WCH than in normotension and its possible impact on outcome should be evaluated in future studies. MH shows significantly higher risk than normotension, although the best way for its detection and treatment remains to be established.

1 August 2009 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
SPSante D. Pierdomenico
Sante D. Pierdomenico
Marta Di NicolaMarta Di Nicola
Marta Di Nicola
AEAnna L. Esposito
Anna L. Esposito
RMRocco Di Mascio
Rocco Di Mascio
EBEnzo Ballone
Enzo Ballone
FCFranco Cuccurullo
Franco Cuccurullo
Background. The independent prognostic significance of different indices of blood pressure (BP) variability is not clear. We investigated the prognosti

1 January 2013 in The American Journal of Cardiology
Verified
Journal Article
Closed access
SPSante D. Pierdomenico
Sante D. Pierdomenico
APAnna M. Pierdomenico
Anna M. Pierdomenico
FCFranco Cuccurullo
Franco Cuccurullo
GIGianluca Iacobellis
Gianluca Iacobellis

1 August 2010 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
SPSante D. Pierdomenico
Sante D. Pierdomenico
FCFranco Cuccurullo
Franco Cuccurullo
Background. The prognostic relevance of echocardiographic left ventricular hypertrophy (LVH) regression in hypertension is uncertain. The aim of this s

1 June 1998 in JACC
Verified
Journal Article
Closed access
SPSante D Pierdomenico
Sante D Pierdomenico
ABAnna Bucci
Anna Bucci
FCFabrizio Costantini
Fabrizio Costantini
DLDomenico Lapenna
Domenico Lapenna
FCFranco Cuccurullo
Franco Cuccurullo
AMAndrea Mezzetti
Andrea Mezzetti